CDLX241115C7000
- 0.09
- 0.000.00%
Cardlytics Newsroom
Cardlytics Announces Timing of Its Third Quarter 2024 Earnings Release
The Analyst Verdict: Cardlytics In The Eyes Of 5 Experts
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Cardlytics Price Target Announced at $4.00/Share by Evercore ISI Group
Evercore Initiates Cardlytics(CDLX.US) With Hold Rating, Announces Target Price $4
Cardlytics: Balancing Strong Partnerships and ARPU Potential With Economic Sensitivity and Operational Risks
Cardlytics Initiated With an In Line at Evercore ISI
Is Cardlytics, Inc. (CDLX) the Worst Marketing Stock to Buy?
Cardlytics, Inc. (CDLX): A Bull Case Theory
Favourable Signals For Cardlytics: Numerous Insiders Acquired Stock
Express News | Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Northland Securities Downgrades Cardlytics(CDLX.US) to Hold Rating, Cuts Target Price to $5
Express News | Cardlytics Inc : Northland Capital Cuts to Market Perform
Northland Securities Downgrades Cardlytics (CDLX) to a Hold
BofA Securities Downgrades Cardlytics(CDLX.US) to Sell Rating
Express News | Cardlytics Inc : BofA Global Research Cuts to Underperform From Neutral; Cuts Price Objective to $3.5 From $4
Bank of America Securities Remains a Sell on Cardlytics (CDLX)
Express News | B of A Securities Downgrades Cardlytics to Underperform, Lowers Price Target to $3.5
Craig-Hallum Downgrades Cardlytics(CDLX.US) to Hold Rating